Earnings (Loss) Per Common Share

6 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

10. Earnings (Loss) Per Common Share

Basic earnings (loss) per common share is computed by dividing the net income (loss) allocated to common stockholders by the weighted-average number of shares of common stock outstanding during the period. For purposes of calculating diluted earnings (loss) per common share, the denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method. The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):  

	Three Months ended				Six Months ended
	December 31,				December 31,
	2016		2015		2016		2015
Basic and diluted numerator:
Net loss available to iBio, Inc. stockholders	$	(3,229)	$	(2,246)	$	(6,290)	$	(4,051)
Basic and diluted denominator:
Weighted-average common shares outstanding		89,109		77,326		89,109		77,316
Per share amount	$	(0.04)	$	(0.03)	$	(0.07)	$	(0.05)

In Fiscal 2017 and Fiscal 2016, the Company incurred net losses which cannot be diluted; therefore, basic and diluted loss per common share are the same. As of December 31, 2016, shares issuable which could potentially dilute future earnings included approximately 12.3 million stock options.  As of December 31, 2015, shares issuable which could potentially dilute future earnings included approximately 12.1 million stock options and 1.8 million warrants.